Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
162 INR | -0.76% |
|
+2.62% | +0.58% |
05-31 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 | |
05-30 | INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties | RE |
Business Summary
Number of employees: 852
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 14,908 | 100.0 % | 18,521 | 100.0 % | +24.23% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States & North America
41.8
%
| 6,351 | 42.6 % | 7,746 | 41.8 % | +21.97% |
Europe and United Kingdom
41.4
%
| 6,091 | 40.9 % | 7,676 | 41.4 % | +26.02% |
Australia and New Zealand
11.3
%
| 1,798 | 12.1 % | 2,095 | 11.3 % | +16.51% |
Rest of World
5.2
%
| 669 | 4.5 % | 971 | 5.2 % | +45.10% |
India
0.2
%
| - | - | 34 | 0.2 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 15/04/92 | |
Director of Finance/CFO | 55 | 05/09/02 | |
Compliance Officer | - | - | |
Director/Board Member | 70 | 04/07/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sunny Sharma
BRD | Director/Board Member | 49 | 10/08/21 |
Chief Executive Officer | 52 | 15/04/92 | |
Director/Board Member | 52 | 24/09/14 | |
Director/Board Member | 70 | 04/07/16 | |
Director/Board Member | 51 | 13/03/18 | |
Director/Board Member | 71 | 04/10/11 | |
Director/Board Member | 54 | 30/04/16 | |
Shailaja Vardhan
BRD | Director/Board Member | 58 | 30/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 453,163,746 | 253,637,273 ( 55.97 %) | 0 | 55.97 % |
Company contact information
Marksans Pharma Ltd.
Oshiwara, Andheri West Grandeur, Veera Desai Extension Road
400053, Mumbai
+91 22 4001 2000
http://www.marksanspharma.com![address Marksans Pharma Limited(MARKSANS)](https://cdn.zonebourse.com/static/address/9743339.png)
Group companies
Name | Category and Sector |
---|---|
Time-Cap Laboratories, Inc.
![]() Time-Cap Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Time-Cap Laboratories, Inc. offers pharmaceutical tablets and capsules. It offers diverse formulations including analgesics, laxatives, dietary supplements, cough & cold medications, prescription drugs, and several other products. The company was founded in 1979 and is headquartered in Farmingdale, NY. |
Pharmaceuticals: Major
|
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.58% | 887M | |
+54.61% | 815B | |
+44.25% | 654B | |
-6.33% | 354B | |
+20.62% | 337B | |
+10.44% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.61% | 171B |
- Stock Market
- Equities
- MARKSANS Stock
- Company Marksans Pharma Limited